|
Acambis PLC - Company Profile Snapshot
| Company Profile: |
Acambis PLC |
| Ticker: |
ACM |
| Exchanges: |
LON |
| 2007 Sales: |
9,500,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
UNITED KINGDOM |
| Employees: |
206 |
Business Description
Acambis PLC. The Group's principal activity is researching, developing and manufacturing vaccines to prevent and treat infectious diseases. The Group's vaccine product are ChimeriVax-JE and ChimeriVax-West Nile. ChimeriVax-JE is a single-dose vaccine for travellers and those living in endemic regions. ChimeriVax-West Nile focuses on viruses transmitted to humans and animals by the bite of an infected mosquito. The Group's other pipeline products are Clostridium difficile and Influenza vaccine. The Group operates in the United Kingdom and the United States of America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
